GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
3,021
Funds Holding Change
+23
Funds Holding Growth
+0.8%
Value
$613B
Holding in Top 10
574
Top 10 Change
+87
Top 10 Growth
+18%
Value Growth
+11%
New
118
Increased
1,212
Reduced
1,462
Closed
69
Capital Inflow
$19.4B
Capital Outflow
$30.7B
Net Capital Flow
-$11.3B
Capital Flow Change
-$19.8B
Calls
$6.2B
Puts
$7.32B
Net Calls
-$1.12B
Put/Call Ratio
1.18